Artiva Biotherapeutics: 'Buy' On AlloNK POC And FDA Phase 3 Alignment For Refractory RA

Artiva Biotherapeutics (ARTV) is maintained as a "Buy," driven by FDA alignment for a single phase 3 trial of AlloNK plus ...
Investor's Business Daily on MSN

Alignment Healthcare clears key benchmark, hitting 80-plus RS rating

A Relative Strength Rating upgrade for Alignment Healthcare shows improving technical performance.
Insider Monkey

Simulations Plus (SLP) Highlights FDA Alignment as Citizens Maintains Market Perform

Simulations Plus, Inc. (NASDAQ:SLP) is one of the best healthcare AI stocks to buy now. On December 9, Simulations Plus, Inc. (NASDAQ:SLP) issued a press release highlighting how its technologies ...
Hosted on MSN

Alignment Healthcare Hits 80-Plus Relative Strength Rating Benchmark

On Thursday, Alignment HealthcareALHC hit an important technical milestone, with its Relative Strength (RS) Rating rising into the 80-plus percentile with an upgrade to 84, an increase from 80 the day ...